The effect of lowering salt intake on ambulatory blood pressure to reduce cardiovascular risk in chronic kidney disease (LowSALT CKD study): Protocol of a randomized trial

BMC Nephrology

Volumn 13, Issue 1, 2012, Pages

  McMahon, Emma J ^a,b   Bauer, Judith D ^b   Hawley, Carmel M ^a   Isbel, Nicole M ^a   Stowasser, Michael ^a,b   Johnson, David W ^a,b   Hale, Rachael E ^a   Campbell, Katrina L ^a,b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Arterial stiffness; Blood pressure; Cardiovascular disease; Chronic kidney disease; Clinical trial; Dietary sodium; Patient compliance; Taste disturbance

Indexed keywords

ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL EFFECTIVENESS; HUMAN; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PROTEINURIA; PULSE WAVE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SODIUM RESTRICTION; TASTE;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; CROSS-OVER STUDIES; DIET, SODIUM-RESTRICTED; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SODIUM CHLORIDE, DIETARY; TREATMENT OUTCOME;

EID: 84867617557     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-13-137     Document Type: Article

References (69)

1. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. Go AS, et al. N Engl J Med 2004 351 13 1296 1305 10.1056/NEJMoa041031 15385656 (Pubitemid 39268908)
2. Cardiovascular implications of proteinuria: an indicator of chronic kidney disease. Agrawal V, et al. Nat Rev Cardiol 2009 6 4 301 311 10.1038/nrcardio.2009.11 19352334
3. Cardiovascular remodelling and extracellular fluid excess in early stages of chronic kidney disease. Essig M, et al. Nephrol Dial Transplant 2008 23 1 239 248 17704109 (Pubitemid 351767367)
4. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. Sacks FM, et al. N Engl J Med 2001 344 1 3 10 10.1056/NEJM200101043440101 11136953 (Pubitemid 32064838)
5. Salt-a potential 'uremic toxin'? Ritz E, et al. Blood Purif 2006 24 1 63 66 10.1159/000089439 16361843 (Pubitemid 41820824)
6. Effects of sodium restriction and cyclooxygenase-2 inhibition on the course of hypertension, proteinuria and cardiac hypertrophy in Ren-2 transgenic rats. Vaneckova I, et al. Physiol Res 2005 54 1 17 24 15717837 (Pubitemid 40363650)
7. Sodium intake affects urinary albumin excretion especially in overweight subjects. Verhave JC, et al. J Intern Med 2004 256 4 324 330 10.1111/j.1365-2796.2004.01390.x 15367175 (Pubitemid 39304344)
8. Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuria. Anavekar NS, et al. Kidney Int Suppl 2004 92 50 S55 15485418
9. Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Borch-Johnsen K, Kreiner S, Br Med J (Clin Res Ed) 1987 294 6588 1651 1654 10.1136/bmj.294.6588.1651 (Pubitemid 17088017)
10. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. Jurgens G, Graudal NA, Cochrane Database Syst Rev 2004 11 D004022
11. Effect of longer-term modest salt reduction on blood pressure. He FJ, MacGregor GA, Cochrane Database Syst Rev 2004 2004 3 D004937
12. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: a meta-analysis. Graudal NA, Galloe AM, Garred P, JAMA 1998 279 17 1383 1391 10.1001/jama.279.17.1383 9582047 (Pubitemid 28198806)
13. Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. Midgley JP, et al. JAMA 1996 275 20 1590 1597 10.1001/jama.1996.03530440070039 8622251 (Pubitemid 26154246)
14. Systematic review of long term effects of advice to reduce dietary salt in adults. Hooper L, et al. BMJ 2002 325 7365 628 10.1136/bmj.325.7365.628 12242173
15. Salt sensitivity and circadian rhythm of blood pressure: the keys to connect CKD with cardiovascular events. Kimura G, Dohi Y, Fukuda M, Hypertens Res 2010 33 6 515 520 10.1038/hr.2010.47 20379191
16. Salt sensitivity of blood pressure in chronic renal failure. Evidence for renal control of body fluid distribution in man. Koomans HA, et al. Hypertension 1982 4 2 190 197 10.1161/01.HYP.4.2.190 7040224 (Pubitemid 12162017)
17. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Coresh J, et al. Am J Kidney Dis 2003 41 1 12 12500213 (Pubitemid 36043346)
18. Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. Vogt L, et al. J Am Soc Nephrol 2008 19 5 999 1007 10.1681/ASN.2007060693 18272844
19. Daily sodium intake in chronic kidney disease patients under nephrology clinic follow-up: an observational study with 24-hour urine sodium measurement. Aybal A, et al. NDT Plus 2009 2 suppl 2 i219
20. Global approach to cardiovascular risk in chronic kidney disease: Reality and opportunities for intervention. De Nicola L, et al. Kidney Int 2006 69 3 538 545 10.1038/sj.ki.5000085 16395261 (Pubitemid 43164447)
21. Benefits of dietary sodium restriction in the management of chronic kidney disease. Krikken JA, Laverman GD, Navis G, Curr Opin Nephrol Hypertens 2009 18 6 531 538 10.1097/MNH.0b013e3283312fc8 19713840
22. Evidence based practice guidelines for the nutritional management of chronic kidney disease. Ash S, et al. Nutr Diet 2006 63 s2 33 S45 10.1111/j.1747-0080.2006.00100.x
23. EBPG guideline on nutrition. Fouque D, et al. Nephrol Dial Transplant 2007 22 Suppl 2 i45 ii87 17507426
24. European Guidelines for the Nutritional Care of Adult Renal Patients 2002 http://www.eesc.europa.eu/self-and-coregulation/documents/codes/private/086- private-act.pdf.
25. Voss D, Nutrition and growth in kidney disease: Sodium in pre-dialysis patients CARI guidelines 2005 http://www.cari.org.au/CKD-nutrition-list- published/Sodium-in-pre-dialysis.pdf.
26. Guidelines for the management of chronic kidney disease. Levin A, et al. Cmaj 2008 179 11 1154 62 10.1503/cmaj.080351 19015566
27. Estimates of interdialytic sodium and water intake based on the balance principle: differences between nondiabetic and diabetic subjects on hemodialysis. Ramdeen G, et al. ASAIO J 1998 44 6 812 7 10.1097/00002480- 199811000-00009 9831090 (Pubitemid 28514299)
28. Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease. Bellizzi V, et al. Kidney Int 2007 71 3 245 51 10.1038/sj.ki.5001955 17035939 (Pubitemid 46160925)
29. U.S. Department of Agriculture and U.S. Department of Health and Human Services, Dietary Guidelines for Americans, 2010 Washington, DC: U.S: Government Printing Office 7 2010
30. NEMO Renal Group, Low Salt Diet http://www.health.qld.gov.au/nutrition/ resources/renal-lowsalt.pdf
31. Heart Failure Society of America, Module 2: How to follow a low salt diet. Educational Modules on Heart Failure 2002 [cited 2011 11th April] 2012 http://www.hfsa.org/heart-failure-education-modules.asp
32. Sodium balance in renal failure. A comparison of patients with normal subjects under extremes of sodium intake. Koomans HA, et al. Hypertension 1985 7 5 714 21 10.1161/01.HYP.7.5.714 3897045 (Pubitemid 15238769)
33. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. O'Brien E, et al. J Hypertens 2005 23 4 697 701 10.1097/01.hjh.0000163132.84890.c4 15775768 (Pubitemid 40523262)
34. Usefulness of assessing masked and white-coat hypertension by ambulatory blood pressure monitoring for determining prevalent risk of chronic kidney disease: the Ohasama study. Kanno A, et al. Hypertens Res 2010 33 11 1192 8 10.1038/hr.2010.139 20703228
35. Masked hypertension and white-coat hypertension in chronic kidney disease: a meta-analysis. Bangash F, Agarwal R, Clin J Am Soc Nephrol 2009 4 3 656 64 10.2215/CJN.05391008 19261815
36. Pain, sleep disturbance, and quality of life in patients with chronic kidney disease. Cohen SD, et al. Clin J Am Soc Nephrol 2007 2 5 919 25 10.2215/CJN.00820207 17702733
37. Comparison of ankle-brachial index and brachial-ankle pulse wave velocity between patients with chronic kidney disease and hemodialysis [Abstract]. Chen SC, et al. Am J Nephrol 2009 29 5 374 80 10.1159/000168485 18974638
38. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Pimenta E, et al. Hypertension 2009 54 3 475 481 10.1161/HYPERTENSIONAHA.109.131235 19620517
39. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Laurent S, et al. Eur Heart J 2006 27 21 2588 605 10.1093/eurheartj/ehl254 17000623 (Pubitemid 44627304)
40. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. Wilkinson IB, et al. J Hypertens 1998 16 12 Pt 2 2079 84 9886900 (Pubitemid 29002391)
41. SphymoCor CMV Research Applications Manual, AtCor Medical Pty Ltd.: Sydney 2010
42. Agrawal V, et al. Cardiovascular Implications of Proteinuria: An Indicator of Chronic Kidney Disease: Measurement of Proteinuria Medscape Education http://www.medscape.org/viewarticle/590102-2
43. Fresenius Medical Care, Body Composition Monitor. [cited 2011 19/01] 2011 http://www.bcm-fresenius.com/index.html
44. Wabel P, et al. Accuracy of bioimpedance spectroscopy (BIS) to detect fluid status changes is hemodialysis patients http://www.bcm-fresenius.com/ mediafiles/Pre-Post-Poster-EDTA-2007.pdf.
45. Body fluid volume determination via body composition spectroscopy in health and disease. Moissl UM, et al. Physiol Meas 2006 27 9 921 33 10.1088/0967-3334/27/9/012 16868355 (Pubitemid 44131442)
46. Body Composition Monitor 2010 http://www.bcm-fresenius.com/index.html
47. The Xerostomia Inventory: a multi-item approach to measuring dry mouth. Thomson WM, et al. Community Dent Health 1999 16 1 12 7 10697349
48. Measuring change in dry-mouth symptoms over time using the Xerostomia Inventory. Thomson WM, Gerodontology 2007 24 1 30 5 10.1111/j.1741-2358.2007. 00137.x 17302928
49. Further testing of the xerostomia inventory. Thomson WM, Williams SM, Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000 89 1 46 50 10.1016/S1079-2104(00)80013-X 10630941
50. World Health Organization, Adherence to long-term therapies: evidence for action World Health Organisation 2003 http://www.who.int/chp/knowledge/ publications/adherence-report/en/
51. Elliot P, Brown I, Sodium intakes around the world: background document prepared for the forum and technical meeting on reducing salt intake in populations 2006 http://www.who.int/dietphysicalactivity/Elliot-brown-2007.pdf
52. Development and validation of a short questionnaire to assess sodium intake. Charlton KE, et al. Public Health Nutr 2007 11 1 83 94 17582243
53. Estimation of salt intake from spot urine samples in patients with chronic kidney disease. Ogura M, et al. BMC Nephrol 2012 13 1 36 10.1186/1471-2369-13-36 22682402
54. Use of mean spot urine sodium concentrations to estimate daily sodium intake in patients with chronic kidney disease. Kang SS, et al. Nutrition 2012 28 3 256 61 10.1016/j.nut.2011.06.006 21996048
55. The Dietary History as a Tool in Research. Burke BS, J Am Diet Assoc 1947 23 1041 1046
56. Martin G, The interviewer-administered, open-ended diet history method for assessing usual dietary intakes in clinical research: relative and criterion validation studies, in Department of biomedical science Wollongong: University of Wollongong 2004 303
57. Generalized Self-Efficacy scale. Jerusalem M, Schwarzer R, Measures in health psychology: A user's portfolio. Causal and control beliefs Windsor, UK: NFER-NELSON, Johnston M, Weinman SWJ, 1995 35 37 22506847
58. Development and validation of the health locus of control (HLC) scale. Wallston BS, et al. J Consult Clin Psychol 1976 44 4 580 5 939841
59. Benefits of and barriers to dietary sodium adherence. Welch JL, et al. West J Nurs Res 2006 28 2 162 80 10.1177/0193945905282323 16513918 (Pubitemid 43394568)
60. Attitudes and barriers to dietary advice aimed at reducing risk of type 2 diabetes in first-degree relatives of patients with type 2 diabetes. Brekke HK, et al. J Hum Nutr Diet 2004 17 6 513 21 10.1111/j.1365-277X.2004.00566.x 15546428 (Pubitemid 39585594)
61. Influence of salt deficiency on taste sensitivity in human subjects. Yensen R, Nature 1958 181 4621 1472 4 10.1038/1811472a0 13552703
62. International Organization for Standardization, Sensory analysis - methodology - method of investigating sensitivity of taste: ISO 3972:2011 1991 http://www.iso.org/iso/home/store/catalogue-ics/catalogue-detail-ics.htm? csnumber=50110
63. Health-related quality of life outcomes in chronic kidney disease. Soni RK, Weisbord SD, Unruh ML, Curr Opin Nephrol Hypertens 2010 19 2 153 9 10.1097/MNH.0b013e328335f939 20051850
64. Dietary salt loading impairs arterial vascular reactivity. Todd AS, et al. Am J Clin Nutr 2010 91 3 557 64 10.3945/ajcn.2009.28645 20107199
65. LP S, STATA Data Analysis and Statistical Software. 2012 [cited 2012 September 26] 2012 http://www.stata.com/
66. Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. Agarwal R, Andersen MJ, Kidney Int 2006 69 7 1175 80 10.1038/sj.ki.5000247 16467785
67. Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients. Haydar AA, et al. Kidney Int 2004 65 5 1790 4 10.1111/j.1523-1755.2004.00581.x 15086918 (Pubitemid 38591027)
68. Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials. Geleijnse JM, Kok FJ, Grobbee DE, J Hum Hypertens 2003 17 7 471 80 10.1038/sj.jhh.1001575 12821954 (Pubitemid 36903334)
69. Reductions in blood pressure following energy restriction for weight loss do not rebound after re-establishment of energy balance in overweight and obese subjects. Brinkworth GD, et al. Clin Exp Hypertens 2008 30 5 385 96 10.1080/10641960802275734 18633761 (Pubitemid 352009298)